Table 5: Changes overtime in the degree of proteinuria in the two groups of the studied cases.
| G I (n = 50) | G II (n = 50) | P- value | ||
| Proteinuria 0 | 2.02 ± 0.89 | 1.94 ± 0.84 | P 0-1 | 0.87 |
| Proteinuria 1 | 1.48 ± 0.58 | 1.86 ± 0.81 | P 0-2 | 0.02 |
| Proteinuria 2 | 0.78 ± 0.82 | 1.46 ± 0.79 | P 1-2 | 0.00 |
| Paired difference0-1 & (P0-1) |
0.54 ± 0.59 0.00 |
0.08 ± 0.44 0.21 |
||
| Paired difference0-2 & (P0-2) |
1.24 ± 0.66 0.00 |
0.48 ± 0.97 0.001 |
||
| Paired difference1-2 & (P1-2) |
0.70 ± 0.58 0.00 |
0.4 ± 0.99 0.006 |
||
G I: group I (received NAC supplementation); G IV: group IV (received none of the supplements); 0 denotes the time of diagnosis of preeclampsia; 1 denotes the first follow up; after 4 weeks of treatment and 2 refers to the second follow up after 6 weeks of treatment. P-value is significant at ≤ 0.05.